Rapid Data Analysis – Tolperisone drug utilisation

Study identification

• EU PAS number:
  EUPAS40290
• Study ID:
  40291
• Official title and acronym:
  Rapid Data Analysis – Tolperisone drug utilisation
• DARWIN EU® study:
  No
• Study countries:
  Germany
• Study description:
  This was a study of drug utilisation of tolperisone in Germany with yearly data on number of patients with a prescription, number of prescriptions, number of new users, and indication for treatment (classified as 'in-label' in accordance with new label) between January 2009 and June 2020. Results were stratified by gender, age group and type of practice.
• Study status:
  Finalised

Research institutions and networks

Institutions

European Medicines Agency (EMA)

Study timelines

Date when funding contract was signed

Planned:03/02/2020

Actual:03/02/2020

Study start date

Planned:08/01/2021

Actual:08/01/2021

Data analysis start date

Planned:08/01/2021

Actual:08/01/2021

Date of final study report

Planned:15/02/2021

Actual:15/02/2021

Sources of funding

EMA

Regulatory

• Was the study required by a regulatory body?:
  Yes
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable